Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-015020
Filing Date
2023-06-08
Accepted
2023-06-08 21:40:07
Documents
1
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6120
  Complete submission text file 0000899243-23-015020.txt   7592
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Issuer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 171 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Rothenberg Mace (Reporting) CIK: 0001873988 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39485 | Film No.: 231003699